Effects of Midwife-Centered Acupressure (MID-CURE) at LI4, GB21 and SP6 points on Maternal, Delivery and Neonatal outcome among primi-parturient women during first stage of labour admitted in Tertiary care hospital: A Double-Blinded Randomized Sham Controlled Clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 292
- 试验地点
- 1
- 主要终点
- 1. To determine the efficacy of Midwife-centered acupressure (MID-CURE) on maternal, delivery, and neonatal outcome among primi-parturient women in the first stage of labour within and between LI4, GB21 and SP6 intervention groups and sham control group
研究概览
简要总结
Acupressure has been used as a complementary therapy for labor pain management and to potentially facilitate labor progression. By using acupressure at specific points, the study seeks to examine whether it improves maternal and neonatal outcomes and provides a safer, less invasive alternative to pharmacological pain relief methods. The randomized controlled design allows for rigorous testing of the hypothesis and can help establish whether there is a real benefit to acupressure over a sham treatment. If the study finds positive results, it could lead to the wider adoption of acupressure as a non-pharmacological tool for managing labor pain and improving outcomes for both mothers and newborns. The study may also contribute to the broader understanding of how complementary therapies can be integrated into maternity care, particularly in settings like tertiary care hospitals where women may have access to more resources. MID-CURE refers to a midwife-centered approach to applying acupressure during labor, particularly at specific acupuncture points. LI4 (Hegu): Known to help with labor pain relief and facilitate the progression of labor. GB21 (Jianjing): Thought to aid in labor progression and provide pain relief. SP6 (Sanyinjiao): A common point used to help with uterine contractions and reduce labor pain. The intervention aims to evaluate the effects of acupressure applied at these points during the first stage of labor. Neither the participants (women in labor) nor the healthcare providers administering the acupressure know whether the participant is receiving real acupressure or a sham (placebo) treatment. Participants are randomly assigned to either the acupressure treatment group or a control group receiving a sham treatment. This helps to control for the placebo effect. This is a trial where participants are assigned to either the treatment or control group to study the outcomes. The participants are primi-parturient women (women experiencing their first childbirth) who are in the first stage of labor. This is a critical phase when labor begins and progresses with regular contractions but before the cervix fully dilates. Tertiary Care Hospitals: These are advanced medical centers where high-risk pregnancies and deliveries are managed, and they typically have specialized personnel like midwives who can provide care during labor.
Bottom of Form
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 19.00 Year(s) 至 35.00 Year(s)(—)
- 性别
- Female
入选标准
- •Primi parturient women in spontaneous labour with intact membrane. In First stage of labour. Estimated fetal weight of 2.
- •4 kgs. No Significant Medical History or past obstetrics history and without any pregnancy complications.
排除标准
- •Primi-parturient women in use of Epidosin, or Tab Misoprost.
- •Pregnancy after infertility.
- •With Cognitive deficits or impairments.
- •Refusal to continue participation in the study, receiving pain relief drugs 3 hours before or during the study, labour induction or enhancement by medication.
- •during the study.
结局指标
主要结局
1. To determine the efficacy of Midwife-centered acupressure (MID-CURE) on maternal, delivery, and neonatal outcome among primi-parturient women in the first stage of labour within and between LI4, GB21 and SP6 intervention groups and sham control group
时间窗: 1 years
次要结局
- 1. To estimate the maternal, delivery, and neonatal outcome among primi-parturient women before the application of MID-CURE at LI4, GB21 and SP6 intervention groups and sham control group(2. To determine the difference in maternal, delivery, and neonatal outcome among primi-parturient women after the application of at LI4, GB21 and SP6 intervention groups and sham control group)
研究者
Ms Sakila Basnet
Sikkim Manipal College of Nursing, Sikkim Manipal University
